Laennec

Laennec is the ethical drug manufactured with JBP’s unique technologies for effective extraction of 
variety of growth factors, cytokines, and other physiologically active substances from the human placenta. 
For instance, HGF (hepatocyte growth factor) promotes the proliferation of hepatic parenchymal cells for 
recovery of a damaged liver. Our product safety is ensured by the most rigid safety measures among existing 
scientific standards.

Placenta

The placenta provides nutrients and components for immunity during the growth and development of a 
fetus for about 9-10 months, once the embryo is fertilized and the fetus moves to and attaches itself 
to the uterus. The placenta contains many active substances, including physiologically active proteins, 
functional peptides, enzymes, amino acids, lipids, DNA, and RNA.

Placenta and Laennec

Laennec was approved in 2005 as a placental hydrolysate injection, and in 2011, it was the only 
placental hydrolysate to have its efficacy clinically proven.
Besides identifying numerous unknown components of placental hydrolysates with infinite potential, 
GC Wellbeing also researches personalized treatments through scientific studies of disease prevention 
and treatment and slowing down the aging process.

INDICATION

● Whiten skin, and lighten pigments on the skin. 
● Shrink pores to make skin more smooth, reduce oil and reduce darkening.
● Improve elasticity, make skin firmer.
● Remove acne, restore damaged skin.
● Reduce wrinkles.
● Helps skin moisturize quickly.
● Reduce puffiness under eyes.
● Regenerate cells, help wounds heal faster.

DOSAGE AND ADMINISTRATION
● The normal adult dose is a 2ml subcutaneous or intramuscular injection once daily. 
According to symptoms, the dose can be increased to 2 or 3 times daily